Related Experiment Videos
Drug usage and adverse drug reactions in paediatric patients
Insights
Intensive monitoring of 1,000 pediatric admissions revealed fewer drug reactions compared to adults. Adverse drug reactions (ADRs) occurred in 6% of patients, highlighting the need for improved pediatric drug surveillance.
Area of Science:
- Clinical Pharmacology
- Pediatric Medicine
- Epidemiology
Background:
- Adverse drug reactions (ADRs) are a significant concern in pediatric healthcare.
- Understanding drug usage patterns and reaction incidence in hospitalized children is crucial for patient safety.
Purpose of the Study:
- To review epidemiological methods for studying ADRs.
- To present data from intensive monitoring of pediatric admissions regarding drug use and ADRs.
- To compare drug usage and ADRs in UK pediatric inpatients with other populations.
Main Methods:
- Intensive monitoring of 1,000 admissions to a medical pediatric unit.
- Data collection on drug administration and observed adverse events.
- Analysis of ADR frequency, patient characteristics, and management of side-effects.
Main Results:
- Pediatric patients received fewer drugs and experienced fewer ADRs compared to adults and American children.
- Fifty-one percent (6%) of patients experienced 119 ADRs.
- ADRs were more common in children with serious disorders; 55% of ADRs required treatment.
Conclusions:
- Pediatric drug usage patterns differ from general UK and American pediatric practices.
- Current monitoring may underestimate the burden of ADRs in pediatric inpatients.
- Enhanced surveillance programs, including a "therapeutic audit" and community-based monitoring, are recommended for pediatric drug safety.
Abstract:
The development of epidemiological methods for the study of adverse drug reactions is reviewed in connection with the presentation of data obtained by intensive monitoring of 1 000 admissions to a medical paediatric unit. Compared with adults and American children, the patients received fewer drugs and experienced fewer reactions while in hospital. The drug usage pattern was different from that of American paediatric practice and general practice in the United Kingdom. Fifty-one (6%) patients experienced 119 adverse drug reactions. These occurred more frequently in children suffering from serious disorders and in the majority of cases the basic therapy was continued regardless of the severity of the drug side-effects. Treatment was required for the effects of 66 (55%) adverse reactions. It appears that drug monitoring in paediatric practice may be of greater value if surveillance programmes are designed to provide a "therapeutic audit" and extended to include children receiving drugs in the community.